The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme

Int. J. Mol. Sci. 2022, 23(2), 771; https://doi.org/10.3390/ijms23020771
Impact factor: 
5,92